APA (7th ed.) Citation

Oudijk, M. A., Wely, M. v., Pajkrt, E., Klumper, J., Wassenaer-Leemhuis, A. G. v., Stirum, E. V. J. v. L., . . . Windt, L. v. d. Atosiban versus placebo in the treatment of threatened preterm birth between 30 and 34 weeks gestation: Study protocol of the 4-year APOSTEL 8 follow-up. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Oudijk, Martijn A., Madelon van Wely, Eva Pajkrt, Job Klumper, Aleid G van Wassenaer-Leemhuis, Emilie V J van Limburg Stirum, Janneke Van 't Hooft, and Larissa van der Windt. Atosiban Versus Placebo in the Treatment of Threatened Preterm Birth Between 30 and 34 Weeks Gestation: Study Protocol of the 4-year APOSTEL 8 Follow-up. BMJ Publishing Group.

MLA (9th ed.) Citation

Oudijk, Martijn A., et al. Atosiban Versus Placebo in the Treatment of Threatened Preterm Birth Between 30 and 34 Weeks Gestation: Study Protocol of the 4-year APOSTEL 8 Follow-up. BMJ Publishing Group.